In Memoriam

In memoriam: Thomas R. Tephly

ASBMB Today Staff
Aug. 8, 2022

Thomas "Tom" R. Tephly, a toxicology and glucuronidation researcher and a member of the American Society for Biochemistry and Molecular Biology for almost 50 years, died July 24, 2021, in Iowa City, Iowa, the ASBMB learned recently. He was 85.

Thomas Tephly

Tephly was born Feb. 1, 1936, in Norwich, Connecticut, to the former Anna Pieniadz and Samuel Tephly, a Polish immigrant. While recuperating from a broken leg, he started taking accordion lessons, and he had his own radio show by the time he was 10, taking requests to play popular polkas. He later learned to play the piano, clarinet and saxophone.

After graduating from the Norwich Free Academy, Tephly earned a B.S. in pharmacy from the University of Connecticut, a Ph.D. in pharmacology from the University of Wisconsin and an M.D. from the University of Minnesota, where he also did postdoctoral studies and was named a research scholar by the American Cancer Society.

Tephly was on the faculty at the University of Michigan for a few years before he moved to the University of Iowa in 1971 to lead a new toxicology center. He retired 32 years later.

Early in his career, Tephly studied how methanol harms mammals through its conversion to formic acid, which inhibits cytochromes and can lead to methanol poisoning symptoms such as blindness and kidney failure. That work led him to studies of aspartame, a dipeptide sweetener introduced in the U.S. in the 1980s that was subject of widespread concerns about safety linked to its metabolism to methanol during digestion. Studies, including several that Tephly collaborated on, found no evidence that ingesting aspartame introduced methanol into the bloodstream, and the Food and Drug Administration and National Cancer Institute concluded it was safe. (People who have the metabolic disease phenylketonuria should avoid aspartame because it is broken down to produce a lot of phenylalanine.)

Later, Tephly became interested in a large family of enzymes called UDP-glucuronosyltransferases, or UGTs, several of which his lab identified. UGTs attach the sugar glucuronic acid onto hormones, drugs, and xenobiotic molecules; Tephly studied their activity on opioids, chemotherapeutic drugs and other molecules. Glucuronidation can make a molecule more water soluble and tends to speed up clearance.

In 1971, he became the youngest recipient of the John J. Abel Award for research in pharmacology. He later received a Fogarty Senior International Fellowship and the Kenneth P. Dubois Award for his contributions to toxicology. In addition to the ASBMB, he was a member of the American Society of Pharmacology and Experimental Therapeutics, the Society of Toxicology, the American Association for Advancement of Science and the International Society for the Study of Xenobiotics.

Tephly married Joan Clifcorn in 1960, and the two raised three daughters. In addition to his lifelong love of music, he enjoyed college sports, cooking, birdwatching and telling his children and grandchildren stories about a naughty bear named Little Brown Bruno.

He is survived by his wife; his daughters, Susan, Linda, and Annette, and their husbands; and four granddaughters.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Related articles

In memoriam: Sten Orrenius
ASBMB Today Staff
2025 PROLAB awardees announced
Marissa Locke Rottinghaus

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Attie named honorary professor
Member News

Attie named honorary professor

Aug. 18, 2025

This award includes $100,000 of research funding and recognizes faculty who have made major contributions to the advancement of knowledge through their research, teaching and service activities.

Meet the 2025 SOC grant awardees
Outreach

Meet the 2025 SOC grant awardees

Aug. 15, 2025

Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

In memoriam: William S. Sly
In Memoriam

In memoriam: William S. Sly

Aug. 11, 2025

He served on the American Society for Biochemistry and Molecular Biology Council in 2005 and 2006 and was an ASBMB member for 35 years.